Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Hungary Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20061
20073
20082
20105
20111
20121
20132
20161
20172
20201
20211
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated4
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Janssen-Cilag International NV4
ACADIA Pharmaceuticals Inc.3
AstraZeneca2
Boehringer Ingelheim2
Hoffmann-La Roche2
Janssen Research & Development, LLC2
Solvay Pharmaceuticals2
Sumitomo Pharma America, Inc.2
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia29
Psychotic Disorders4
Autistic Disorder2
Bipolar Disorder1
Body Weight Changes1
Cognitive Dysfunction1
Mania1
Recurrence1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.